Suppr超能文献

定量呼气末二氧化碳分压测定能否区分呼吸窘迫的心脏性和梗阻性病因?

Can quantitative capnometry differentiate between cardiac and obstructive causes of respiratory distress?

作者信息

Brown L H, Gough J E, Seim R H

机构信息

Department of Emergency Medicine, East Carolina University School of Medicine, Greenville, NC, USA.

出版信息

Chest. 1998 Feb;113(2):323-6. doi: 10.1378/chest.113.2.323.

Abstract

STUDY OBJECTIVE

To determine whether quantitative measurement of end-tidal carbon dioxide (ETCO2) can differentiate between cardiac and obstructive causes of respiratory distress.

DESIGN

Prospective observational study.

SETTING

Emergency department (ED) of a tertiary care hospital.

PATIENTS

Adult patients who presented to the ED with moderate-to-severe dyspnea. Patients were excluded if they were unable to cooperate with the performance of peak expiratory flow rate (PEFR) or ETCO2 tests, were younger than 18 years of age, or had received prehospital intervention for their respiratory distress.

INTERVENTIONS

Physicians obtained an ETCO2 level and PEFR prior to ED pharmacologic intervention. A hand-held capnometer with digital read-out was used to obtain the ETCO2 level. The patient's age, sex, initial vital signs, breath sounds and medication history, the presence or absence of diaphoresis and/or orthopnea, the duration of symptoms, the chest radiograph interpretation, and final diagnosis were also recorded.

MEASUREMENTS AND RESULTS

Forty-two patients were eligible for inclusion in the analysis. The mean ETCO2 level was 31.1+/-9.4 mm Hg; the mean PEFR was 161.3+/-53.1 L/min. The ETCO2 levels for pulmonary edema/congestive heart failure (CHF) patients differed significantly from those of asthma/COPD patients (27.1+/-7.8 mm Hg vs 33.4+/-9.6 mm Hg; p=0.0375). However, no single ETCO2 level was found to be a reliable predictor of diagnosis.

CONCLUSION

ETCO2 levels for pulmonary edema/CHF patients differ significantly from those of asthma/COPD patients. However, no single ETCO2 level reliably differentiates between the two disease processes.

摘要

研究目的

确定呼气末二氧化碳(ETCO2)的定量测量能否区分呼吸窘迫的心脏性和阻塞性病因。

设计

前瞻性观察研究。

地点

一家三级护理医院的急诊科。

患者

因中度至重度呼吸困难就诊于急诊科的成年患者。若患者无法配合进行呼气峰值流速(PEFR)或ETCO2检测、年龄小于18岁或因呼吸窘迫接受过院前干预,则被排除。

干预措施

医生在急诊科进行药物干预前获取ETCO2水平和PEFR。使用带有数字读数的手持式二氧化碳监测仪获取ETCO2水平。还记录了患者的年龄、性别、初始生命体征、呼吸音和用药史、是否存在出汗和/或端坐呼吸、症状持续时间、胸部X光片解读结果及最终诊断。

测量与结果

42例患者符合纳入分析标准。ETCO2平均水平为31.1±9.4 mmHg;PEFR平均水平为161.3±53.1 L/min。肺水肿/充血性心力衰竭(CHF)患者的ETCO2水平与哮喘/慢性阻塞性肺疾病(COPD)患者的ETCO2水平有显著差异(27.1±7.8 mmHg对33.4±9.6 mmHg;p = 0.0375)。然而,未发现单一的ETCO2水平是诊断的可靠预测指标。

结论

肺水肿/CHF患者的ETCO2水平与哮喘/COPD患者的ETCO2水平有显著差异。然而,单一的ETCO2水平无法可靠地区分这两种疾病过程。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验